Linee guida nazionali e internazionali

LINEE GUIDA

LEUCEMIA MIELOIDE ACUTA (AML)

NCCN Guidelines – Acute Myeloid Leukemia – version 1. 2024

SIES – Diagnostica avanzata delle leucemie mieloidi acute dell’adulto per un corretto inquadramento prognostico: linee-guida della Società Italiana di Ematologia Sperimentale – versione 3.4 settembre 2023

ELN - European Leukemia Net - 2022

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data – 2022

NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021

ESMO - European Society for Medical Oncology - 2020

ASH 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults

ASCO - American Society of Clinical Oncology - 2018

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

LEUCEMIA PROMIELOCITICA ACUTA (LPA)

NCCN Guidelines – Acute Myeloid Leukemia – version 1. 2024

ESMO - European Society for Medical Oncology - 2020

ELN - European Laukemia Net - 2019

NEOPLASIA A CELLULE DENDRITICHE PLASMACITOIDI (BPDCN)

NCCN Guidelines – Acute Myeloid Leukemia – version 1. 2024

NCCN Clinical Practice Guidelines in Oncology – Acute Myeloid Leukemia – version 3.2023

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

LEUCEMIA MIELOIDE ACUTA NON-PROMIELOCITICA

SIE – Società Italiana di Ematologia – versione marzo 2023

©Accademia Nazionale di Medicina | Webmaster | Privacy policy | Realizzato da